No images? Click here Congratulations to Jennifer Doudna on being awarded the 2020 Nobel Prize in Chemistry for her invention of CRISPR. We’re honored to have been partnered with Jennifer, Janice Chen, Lucas Harrington and Trevor Martin - the co-founders of Mammoth Biosciences - since their Series A in May 2018. From left to right: Trevor Martin, Jennifer Doudna, Janice Chen, Ursheet Parikh, Mammoth board member Maneesh Jain, and Lucas Harrington Mayfield partner Arvind Gupta has teamed up with NYT bestselling author Po Bronson to tell a story of science breaking out of the ivory tower and into everyone's lives, in what we eat, wear, take as medicine and build our world with. This science is needed to save our planet from pandemics, climate change, infertility, feelings of futility and more. In this edition:
Ursheet and Arvind Discuss Neuromodulation, Investment Trends, Conscious Capital and More at SynBioBeta 2020Both Ursheet and Arvind spoke at SynBioBeta 2020 - Ursheet shared his perspective on neuromodulation as well as investment trends in engineering biology, and Arvind shared his thoughts on conscious capital and investing in biology to improve human and planetary health. Ursheet Presents Award for Best EHR Advance in UCSF Digital Health Awards, Shares Perspective on Qventus and COVID-19As he presents the award for the best EHR advance, Ursheet shares his perspective on how companies like Qventus have aided in the fight against COVID-19 by streamlining hospital system and government agency operations. AI Startup Qventus Helps Hospitals Navigate Operational Troubles of COVID-19 and Beyond Back in March when the first cases of COVID-19 were appearing in the United States, Qventus stepped up and acted fast. They adapted their AI-based platform for predicting health systems' operational bottlenecks to help hospitals prepare and plan for capacity overloads. Endpoint Health Partners with Vanderbilt to Create World’s First Precision Medicine Trial Network Focused on Critical IllnessCritical care precision health platform Endpoint Health has partnered with Vanderbilt University Medical Center to create a sustained system for conducting phase II and III interventional trials intended to validate precision medicine technologies, therapies, and deployable patient-centric care approaches. Jennifer Doudna Sees CRISPR Gene-Editing Tech as a Swiss Army Knife for COVID-19 and BeyondNobel Laureate and Mammoth Biosciences Co-founder Jennifer Doudna shares her perspective on how CRISPR, with its ability to be reprogrammed, could become an essential tool in the fight against pandemics including COVID-19. Arvind Shares his Perspective on Funding Biology with Conscious Capital to Save the WorldIn order to support human and planetary evolution, we need to evolve as an industry to become conscious capitalists, building business for better rather than business as usual. In this podcast, Arvind shares his perspective on investing in engineering biology and helping scientists create and build companies. |